Understanding impulsivity in Parkinson's patients with deep brain stimulation
Official title: Frontosubthalamic Network Dynamics and Their Modulation During Impulse Control and Decision Making in Parkinson's Disease
Run by University of Oxford · NCT06485986 · Data updated 2026-11-12
This study is testing how deep brain stimulation affects impulsivity in people with Parkinson's disease to see if different settings can help reduce impulsive behavior.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Oxford Academic / other |
| Locations | 1 site (Oxford) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | August 1, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | April 2, 2025 |
| Trial ID | NCT06485986 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older diagnosed with Parkinson's disease who have undergone DBS and may or may not have impulse control disorders.
✕Probably not a fit
Patients with extreme language barriers, other neurological disorders, or those enrolled in conflicting clinical studies may not benefit from this research.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This experimental study aims to investigate the mechanisms behind increased impulsivity in some Parkinson's disease patients who undergo deep brain stimulation (DBS) of the subthalamic nucleus. Participants will engage in decision-making tasks while their DBS devices are toggled on and off, allowing researchers to observe the effects on brain activity through magnetoencephalography (MEG). The study seeks to identify the network effects of DBS and explore alternative stimulation settings that may reduce impulsivity. By analyzing these interactions, the research hopes to provide insights into optimizing DBS for better patient outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved DBS settings that minimize impulsivity in Parkinson's disease patients.
How similar studies have gone: While there have been studies on DBS in Parkinson's disease, this specific focus on impulsivity and network effects is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 years or above. * Diagnosed with Parkinson's disease who have required implanted STN electrodes for DBS in addition to their dopamine replacement therapy. * Diagnosed with or without (control group) impulse control disorders since the diagnosis of Parkinson's Disease. * Participant willing and able to sit in the MEG scanner and follow instructions. * Participant willing and able to delay their morning dose of dopamine replacement therapy for up to four hours (180 minutes experimental time + journey time). Exclusion Criteria: * Patients with extreme language barrier that cannot understand the purpose or instructions of the study despite the use of an interpreter. * Other implanted medical devices that may cause artefacts during MEG recordings. * Participants with a history of co-morbid neurological disorders. * Participant enrolled onto another clinical trial related to a neurological disorder (including Parkinson's disease) that may interfere with the results of this study. * Participants who are unable to sit still in a MEG scanner for the duration of this experiment e.g. patients with chronic pain or osteoarthritis. This will be assessed with their primary clinician
Where it's running
-
John Radcliffe Hospital
Oxford, United Kingdom Recruiting
Study contacts
- Study coordinator: John Eraifej, BSc MBChB MRCS
- Email: john.eraifej@ndcn.ox.ac.uk
- Phone: 01865222763
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prediction-model guided drug choice to prevent impulse control disorders in Parkinson's
This trial tests whether an algorithm-guided approach to prescribing Parkinson’s disease medicines can reduce impulse control problems compared with usual care in adults with Parkinson’s.
-
Speech assessment in patients with Parkinson's disease and impulse control issues
This study tests how deep brain stimulation for impulse control in Parkinson's disease affects patients' speech over time.
-
Using rTMS to treat impulse control disorders in Parkinson's disease
This study is testing if a treatment called rTMS can help people with Parkinson's disease who struggle with impulse control issues feel more in control of their behaviors.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.